Molecular characterization and antibiotic susceptibility of Mycobacterium tuberculosis strains isolated from patients attending an urban hospital in Guatemala

Authors

  • B. Samayoa Escuela de Química Biológica, Facultad de Ciencias Químicas y Farmacia, Universidad de San Carlos de Guatemala
  • A. Xet Mull Escuela de Química Biológica, Facultad de Ciencias Químicas y Farmacia, Universidad de San Carlos de Guatemala
  • T. Velásquez Escuela de Química Biológica, Facultad de Ciencias Químicas y Farmacia, Universidad de San Carlos de Guatemala
  • D. Lau Escuela de Química Biológica, Facultad de Ciencias Químicas y Farmacia, Universidad de San Carlos de Guatemala
  • L. Paz Escuela de Química Biológica, Facultad de Ciencias Químicas y Farmacia, Universidad de San Carlos de Guatemala

DOI:

https://doi.org/10.54495/Rev.Cientifica.v16i1.242

Keywords:

Molecular characterization, antibiotic susceptibility, Mycobacterium tuberculosis strains, patients attending an urban hospital in Guatemala

Abstract

The objectives of this research were the characterization of genetic patterns, antibiotic susceptibility and epidemiological factors associated with infections caused by strains of M. tuberculosis. For this study, strains were obtained from patients who attended the San Juan de Dios General Hospital from 2000 to 2002 by reviewing medical records.


For molecular characterization, the subtyping method called Double Repeated Elements-Polymerase Chain Reaction (DRE-PCR) was used; antibiotic susceptibility was performed through the modified method of proportions. Epidemiological information was obtained through review of medical records. The data was entered into databases and analyzed using the statistical program SPSS version 10.


In the molecular analysis, it was found that 74% of 246 mycobacterial strains evaluated presented grouped genetic patterns and 26% unique patterns, which indicates the simultaneous occurrence of recent infections and reactivations. In the antibiotic susceptibility evaluation, 81% of 95 strains were susceptible to the four antituberculous drugs (rifampin, isoniazid, ethambutol, and streptomycin); 5.3% presented resistance to at least one drug and 6.7%' were classified as multi-resistant, the latter strains being isolated from lung samples. Drug resistance was observed in 7 strains with clustered genetic patterns, from people infected or not with HIV. residents of endemic areas and some who were deprived of liberty.

Downloads

Download data is not yet available.

References

Friedman CR, Stoeckle MY, Johnson WD, and Riley LW. Double-Repetitive-Element PCR

method for subtyping Mycobacterium tuberculosis clinical isolates. J Clin Microbiol

;33:1383-1384, https://doi.org/10.1128/jcm.33.5.1383-1384.1995

Small PM, van Embden JDA. 1994. Molecular epidemiology of tuberculosis, p.569-582. Im. B.R, Bloom ( c d . ) . Tuberculosis: pathogenesis, protection, and control, American Society for Microbiology. Washington D.C, https://doi.org/10.1128/9781555818357.ch33 DOI: https://doi.org/10.1128/9781555818357.ch33

Small PM, Hopewell PC, Singh SP el al. The epidemiology of tuberculosis in San Francisco:

A population-based study using conventional and moleccular methods. N. Eng]. J. Med.

;330:1703-1709, https://doi.org/10.1056/NEJM199406163302402 DOI: https://doi.org/10.1056/NEJM199406163302402

Montero E, Valdivia J . Cardoso-Leao S. Molecular fingerprinting of Mycobacterium tuberculosis isolates obtained in Havana. Cuba, by IS6110 Restriction Fragment Length Polymorphism analysis and by the Double-Repetitive-E1ement PCR method. J. Clin,

Microbiol. 1998;36:3099-3102, https://doi.org/10.1128/JCM.36.10.3099-3102.1998 DOI: https://doi.org/10.1128/JCM.36.10.3099-3102.1998

Pan American Health Organization/World Health Organization. Regional Evaluation Meeting of National TB Control Programs, México, September 2000.

Memoria de Labores, Programa Nacional de Tuberculosis. Guatemala, Septiembre 2000

(Memoirs, National Program of Tuberculosis, Guatemala, September, 2002).

Genewein A, Telenti A, Bernasconi C, et al. Molecular approach to identifying rout of

transmission of tuberculosis in the community. Lancet 1993:342:841-844, https://doi.org/10.1016/0140-6736(93)92698-S DOI: https://doi.org/10.1016/0140-6736(93)92698-S

Daley CL, Small PM. Schecter G F et al. An outbreak of tuberculosis with accelerated progressio among persons infected with the human inmunodcficiency virus: An analysis using

restriction -fragment-length polymorphisms. N. Engl. J. Med. 1992;326:231-235, https://doi.org/10.1056/NEJM199201233260404 DOI: https://doi.org/10.1056/NEJM199201233260404

Sepkowitz KA, Raffalli J, Riley LW, Kiehn TE, Armstrong D. Tuberculosis in the AIDS era. Clin Microbiol Rev 1995; 8(2): 180-199, https://doi.org/10.1128/CMR.8.2.180

Caminero Luna J.A . Resistencia primaria a fármacos antituberculosos. Medicina clínica 1989, Vol 93 (l):52-56

Schu1t- Gerowi11 H. On development of mycobacterial infections, LA review concerning

the common situation. Zentralbl Bakteriol 1995 Nov; 283(1):5-13

Thomsen V.O. et a l . Results from 8 yrs of susceptibility testting of clinical Mycobacterium

tuberculosis isolates in Denmark. Eur. Respir. J. 2000 Aug; 16(2):203-8, https://doi.org/10.1183/09031936.00.16220300 DOI: https://doi.org/10.1183/09031936.00.16220300

Narita M. et al . Treatment Experience of Multidrug-Resistant Tuberculosis in Florida.

-1997. Chest 2001; (120): 343-348, https://doi.org/10.1378/chest.120.2.343 DOI: https://doi.org/10.1378/chest.120.2.343

García-García M.L, et al. Clinical consequences and transmissibility of drug-resistant tuberculosis in southern Mexico. Arch. Intern. Med. 2000 Mar 13: 160(5): 630-6, https://doi.org/10.1001/archinte.160.5.630 DOI: https://doi.org/10.1001/archinte.160.5.630

Becerra M.C. et al. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. Int. J, Tuberc. Lung Dis. 2000 Feb;4(2):108-14

Bastian T; Colebunders R. Treatment and prevention of multidrug-resistant tuberculosis.

Drugs 1999 Oct; 5 8 (4)?633-61, https://doi.org/10.2165/00003495-199958040-00005 DOI: https://doi.org/10.2165/00003495-199958040-00005

De Kantor I.N.; Latini O; Barrera L. La resistencia y mullirresistencia a los medicamentos

antituberculosos en la Argentina y en otros países de América Latina. Medicina (B Aires) 1998:58 (2) : 202-8

Mertz B.L.; Douce R.W.; Brito N , Anti-tuberculosis drug resistance in two clinics in Ecuador. Im J tuberc Lung Dis 2000 Feb; 4 (2) : 115-7

de la Hoz R.E. el al. Initial screening for antituberculous drug resistance at inpatient facility in Leon , Nicaragua. Am. J. Trop. Med. Hyg. 1997 Jan;56 (1) : 24-6, https://doi.org/10.4269/ajtmh.1997.56.24 DOI: https://doi.org/10.4269/ajtmh.1997.56.24

Willcox P.A. Drug-resistant tuberculosis. Curr. Opin. Pulm. Med. 2000 May;6 (3): 198-202,

https://doi.org/10.1097/00063198-200005000-00006 DOI: https://doi.org/10.1097/00063198-200005000-00006

Espinal M.A. et al. Global trends in resistance to tuberculosis drugs. N. Engl. J. Med. 2001; 344 (17) : 1294-1303, https://doi.org/10.1056/NEJM200104263441706 DOI: https://doi.org/10.1056/NEJM200104263441706

Loiez-Durocher C: Vachcc A; Lemaitre N. Drug resistance in Mycobacterium tuberculosis:

diagnostic methods. Ann. Biol. Clin. (Paris) 2000 May-Jun; 58 (3) : 291-7, https://doi.org/10.1097/00063198-200005000-00003

Johnson JL; Ellner JJ. Adult tuberculosis overview: African versus Western perspectives. Curr. Opin. Pulm. Med. 2000 May; 6 (3) : 180 —6 DOI: https://doi.org/10.1097/00063198-200005000-00003

Ait Khaled N; Enarson D; Billo N. The epidemiology of tuberculosis and of the resistance

to aniilubcrcitlar agents. Rev. Mai. Respir. 1997 Dec; 14 Suppl 5: S8-18

Arathoon E., et al. Trends and patterns in HIV/AIDS epidemic in Guatemala City during 1994-95. In: International Conference of AIDS. 1996

World Health Organization. Report on the Tuberculosis Epidemic. Geneva:1996

Hudelson P. Gender differentials in tuberculosis: the role of socio-economic and cultural factors. Tuber. Lung. Dis. 1996;7 7( 5 j: 39 1-400, https://doi.org/10.1016/S0962-8479(96)90110-0 DOI: https://doi.org/10.1016/S0962-8479(96)90110-0

Holden C. Stalking a killer in Russian’s Prisons. Science 1999:286:1670, https://doi.org/10.1126/science.286.5445.1670 DOI: https://doi.org/10.1126/science.286.5445.1670

Harrow EM, Rangel J, Arriaga M, et al. Epidemiology and Clinical Consequences of Drug-Resistant Tubcrcuclosis in a Guatemalan Hospital. Chest 1998;113:1452-58, https://doi.org/10.1378/chest.113.6.1452 DOI: https://doi.org/10.1378/chest.113.6.1452

Velasquez ,TI. Samayoa, B. Determinación de la susceptibilidad antibiótica d e cepas de micobacterias aisladas de pacientes que acuden al Hospital General San Juan de Dios. Universidad de San Carlos de Guatemala. Dirección General de Investigación -DIGI En prensa.

Haas. DW, and Des Prez, RM . (1995) Mycobacterium tuberculosis. In Principles and practice of Infectious Diseases, Mandell GL, Bennett JE, Dolin R, eds., New York, Churchill Livingstone.

Sep Kowitz, KA. Raffalli J. Riley LJ. Kiehn, TE, Armstrong, D. (1995) Tuberculosis in the AIDS era. Clin, Microbiol. Rev. 8:180-199, https://doi.org/10.1128/CMR.8.2.180 DOI: https://doi.org/10.1128/CMR.8.2.180

Harris E. A low cost approach to PCR. (1998) Oxford University Press. INC. (118-132).

Velasquez, Tl. Samayoa, B.Diagnóstico de la infección por micobacterias e identificación de sus factores de riesgo en personas viviendo con VIH/SIDA, a través de un programa de entrenamiento docente. Universidad de San Carlos de Guatemala, Dirección General de Investigación -DIGI -. En prensa.

D. Lau.A.M. Xet, B. Samayoa, T. Velasqucz-Porta. E. Arathoon. Determination of genetic

variability in strains of Mycobacterium tuberculosis using DRE-PCR. XIV International

AIDS Conference. Barcelona. 2002. Abstract ThPeB7272

Hopewell, PC. Small P. Applications of Molecular Epidemiology to the prevention, control and study of Tuberculosis en Taller -PCR. INCAP. 1999

Taller: Transferencia de tecnología para el diagnóstico y epidemiología molecular de dengue, tuberculosis y enfermedades diarréicas. INCAP, 1999.

Hance, AJ, Crandchamp, B. Levy-Frebault. V, Lecossicr, D, Rauzier, J, Bocart. D, Gicquel, B.

Detection and identification of mycobacterial DNA. Mol. Microbiol. 3:843-849,

https://doi.org/10.1111/j.1365-2958.1989.tb00233.x DOI: https://doi.org/10.1111/j.1365-2958.1989.tb00233.x

Hermans. PWM, Scuitema. ARJ. Soolingcn, DV, Verstynen, CPIIJ, Bilk. EM, Thole JER, Kolk AHJ, van Embden IDA. 1990. Specific detection of Mycobacterium tuberculosis complex strains by polymerase chain reaction. J. Clin. Microbiol. 28:1204-1213, https://doi.org/10.1128/jcm.28.6.1204-1213.1990 DOI: https://doi.org/10.1128/jcm.28.6.1204-1213.1990

Samayoa B. et al. Impacto Socioeconómico de la epidemia VIH/SIDA en Guatemala, Rev Med Nol Vol5 1995 (p4-10)

Frieden TR, Sherman LF, Maw KL, et al: A multi- institutional outbreak of highly drug resistant tuberculosis. JAMA 1996:276:1229. DOI: https://doi.org/10.1001/jama.1996.03540150031027

Kenyon TA. Ridzon R. Luski-Hawk R, et al: a nosocomial outbreak of multidrug resistant

tuberculosis. Ann. Intern. Med. 1997:127:32, https://doi.org/10.7326/0003-4819-127-1- DOI: https://doi.org/10.7326/0003-4819-127-1-199707010-00006

-00006

Friedman, CR, Stoecle, MY, Johnson Jr, WD; Riley, LW. Double-Repetitive-Element PCR

Method for subtyping M. tuberculosis clinical isolates. J. Clin. Microbiol. 1995:33(5):1382-1384, https://doi.org/10.1128/jcm.33.5.1383-1384.1995 DOI: https://doi.org/10.1128/jcm.33.5.1383-1384.1995

American Society Microbiology (ASM).- Clinical Microbiology Procedures Handbook.- USA: 1998

Published

2003-06-30

How to Cite

Samayoa, B., Xet Mull, A., Velásquez , T. ., Lau, D. ., & Paz, L. . (2003). Molecular characterization and antibiotic susceptibility of Mycobacterium tuberculosis strains isolated from patients attending an urban hospital in Guatemala. Revista Científica, 16(1), 73–88. https://doi.org/10.54495/Rev.Cientifica.v16i1.242

Issue

Section

Artículos originales